(Q28378982)

1

0 references

T L Teräväinen

2

0 references

L Malmberg

3

0 references

J Laakso

4

0 references

H Vapaatalo

5

0 references

H Karppanen

British Journal of Pharmacology

6

0 references

language of work or name

English

0 references

publication date

June 1997

0 references

published in

0 references

volume

121

0 references

page(s)

503-10

0 references

issue

3

0 references

cites work

Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

Effects of felodipine on renal function in animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

The heart in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Sodium Metabolism and Requirements in Lactating Rats ,

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Comparison of Cumulative and Non-Cumulative Administration of Vasoactive Agents in Arterial Smooth Muscle Responsesin Vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Cardiovascular effects of felodipine are not antagonized by dietary salt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Cardiovascular and renal effects of the combination of felodipine and metoprolol during a high-salt and a moderate-salt diet in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Renal and cardiovascular effects of acute and chronic administration of felodipine to SHR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021

Main objectives and new aspects of combination treatment of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701166

7 January 2021